Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 May;28(7):713-8.
doi: 10.1007/s00296-007-0504-5. Epub 2007 Dec 19.

Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature

Affiliations
Review

Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature

T Bosman et al. Rheumatol Int. 2008 May.

Abstract

Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare clinical entity, characterized by a chronic inflammation causing thickening of the dura. Adequate therapeutic management is still a matter of debate. We present a patient with an IHCP, non-responsive to corticotherapy. Oral methotrexate was introduced (12.5 mg weekly) and total remission was observed after 6 weeks, both clinically and after neuro-imaging. We conclude that methotrexate can be effective and a therapeutical option in patients with IHCP who are resistant to corticotherapy or present major side-effects of chronic corticosteroids use.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Axial (a) and coronal (b) T1-weighted contrast-enhanced MR images show markedly thickened and enhanced dura extending from the vertex to the tentorium
Fig. 2
Fig. 2
Axial (a) and coronal (b) T1-weighted contrast-enhanced MR images show progression of dural thickening corresponding with the clinical worsening at the time of the biopsy
Fig. 3
Fig. 3
Axial (a) and coronal (b) T1-weighted contrast-enhanced MR images obtained 6 weeks after introduction of methotrexate show regression of dural thickening and enhancement

References

    1. Charcot JM, Joffroy A (1869) Deux cas d’athrophie musculaire progressive avec lésions de la substance gris et des faisceaux antériolatéraux de la melle épinière. Arch Physiol Norm Pathol 2:354–367, 629–649, 744–769
    1. Naffziger HC, Stern WE (1949) Chronic pachymeningitis: report of a case and review of the literature. Arch Neurol Psychiatry 62:383–411 - PubMed
    1. Sylaja PN, Cherian PJ, Das CK, Radhakrishnan VV, Radhakrishnan K (2002) Idiopathic hypertrophic cranial pachymeningitis. Neurol India 50:53–59 - PubMed
    1. D’Andrea G, Trillo G, Celli P, Roperto R, Crispo F, Ferrante L (2004) Idiopathic intracranial hypertrophic pachymeningitis: two case reports and review of the literature. Neurosurg Rev 27:199–204 - DOI - PubMed
    1. Lee YC, Cueng YC, Hsu SW, Lui CC (2003) Idiopathic Hypertrophic Cranial pachymeningitis: Case report with 7 years of imaging follow-up. AJNR 24:119–123 - PMC - PubMed